- D Graham Mackenzie, specialist registrar in public health (gm@nhs.net),
- Sarah H Wild, senior lecturer in public health and epidemiology,
- Philip Rutledge, consultant in medicines management
- Public Health Department, NHS Fife, Cameron House, Leven, Fife KY8 5RG
- Public Health Sciences, University of Edinburgh, Edinburgh EH8 9AG
- Lothian NHS Board, Edinburgh EH8 9RS
EDITOR—Low dose statins are now available for purchase over the counter by people at moderate risk of coronary heart disease (10 year risk of coronary heart disease 10-15%). Eligible people are identified using an assessment of age, sex, and number of risk factors for coronary heart disease as described in guidelines from the Royal Pharmaceutical Society of Great Britain.1 The guidelines also recommend that blood pressure and cholesterol should be checked to identify people at high risk who should see their general practitioner, but these tests are not always available …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012